IFP Advisors Inc Acquires 551 Shares of Maximus, Inc. (NYSE:MMS)

IFP Advisors Inc increased its stake in Maximus, Inc. (NYSE:MMS – Get Rating) by 10.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,955 shares of the health services provider’s stock after purchasing an additional 551 shares during the period. IFP Advisors Inc’s holdings in Maximus were worth $363,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Bessemer Group Inc. lifted its holdings in shares of Maximus by 577.6% during the 3rd quarter. Bessemer Group Inc. now owns 576 shares of the health services provider’s stock worth $33,000 after acquiring an additional 491 shares during the last quarter. Fifth Third Bancorp raised its holdings in shares of Maximus by 588.1% during the 4th quarter. Fifth Third Bancorp now owns 578 shares of the health services provider’s stock valued at $42,000 after buying an additional 494 shares in the last quarter. Wipfli Financial Advisors LLC bought a new stake in Maximus in the 3rd quarter worth approximately $47,000. CWM LLC grew its position in Maximus by 72.2% during the fourth quarter. CWM LLC now owns 916 shares of the health services provider’s stock valued at $67,000 after acquiring an additional 384 shares during the last quarter. Finally, Ronald Blue Trust Inc. lifted its holdings in shares of Maximus by 210.6% in the 4th quarter. Ronald Blue Trust Inc. now owns 1,168 shares of the health services provider’s stock worth $68,000 after acquiring an additional 792 shares during the last quarter. 97.41% of the stock is currently owned by institutional investors.

Insider Activity at Maximus

In other Maximus news, insider Ilene R. Baylinson sold 9,550 shares of the firm’s stock in a transaction dated Friday, February 10th. The shares were sold at an average price of $82.74, for a total value of $790,167.00. Following the completion of the sale, the insider now directly owns 10,044 shares in the company, valued at $831,040.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.30% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

MMS has been the topic of several recent research reports. Raymond James increased their target price on shares of Maximus from $80.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, February 9th. StockNews.com raised Maximus from a “hold” rating to a “buy” rating in a research note on Friday.

Maximus Price Performance

MMS stock opened at $79.45 on Tuesday. The stock has a market capitalization of $4.83 billion, a price-to-earnings ratio of 28.27 and a beta of 0.69. The firm’s 50-day moving average price is $79.81 and its two-hundred day moving average price is $74.18. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 0.75. Maximus, Inc. has a 12-month low of $54.46 and a 12-month high of $85.25.

Maximus (NYSE:MMS – Get Rating) last announced its earnings results on Wednesday, May 3rd. The health services provider reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.02. The company had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.20 billion. Maximus had a return on equity of 15.37% and a net margin of 3.62%. The firm’s revenue for the quarter was up 2.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.07 earnings per share. As a group, equities analysts predict that Maximus, Inc. will post 4.29 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 31st. Stockholders of record on Monday, May 15th will be paid a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date of this dividend is Friday, May 12th. Maximus’s payout ratio is 39.86%.

Maximus Company Profile

(Get Rating)

MAXIMUS, Inc engages in the operation of government health and human services programs, and the provision of technology solutions to government. It operates through the following segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers business process services (BPS), appeals and assessments, and related consulting work for U.S.